Lapatinib

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3709 publications

Food, Dietary Supplement, and Gut Microbiome Interactions in Oral Anticancer Therapy: Mechanisms, Clinical Consequences, and Management.

Food, Dietary Supplement, and Gut Microbiome Interactions in Oral Anticancer Therapy: Mechanisms, Clinical Consequences, and Management.

Journal: American journal of therapeutics

Published: October 14, 2026

Trefoil Factor 1 contributes to Paclitaxel and Lapatinib resistance in brain metastatic breast cancer cells.

Trefoil Factor 1 contributes to Paclitaxel and Lapatinib resistance in brain metastatic breast cancer cells.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: September 28, 2026

Trefoil Factor 1 contributes to Paclitaxel and Lapatinib resistance in brain metastatic breast cancer cells.

Trefoil Factor 1 contributes to Paclitaxel and Lapatinib resistance in brain metastatic breast cancer cells.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: September 28, 2026

Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Journal: British journal of cancer

Published: September 25, 2026

Title Not Found

Title Not Found

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: September 08, 2026

Anti-HER2 tyrosine kinase inhibitors in the management of brain metastases from HER2-positive breast cancer: the role of the community pharmacist

Anti-HER2 tyrosine kinase inhibitors in the management of brain metastases from HER2-positive breast cancer: the role of the community pharmacist

Journal: Annales pharmaceutiques francaises

Published: August 21, 2026

Durable treatment response to Trastuzumab deruxtecan in two patients with recurrent grade III anaplastic ependymoma.

Durable treatment response to Trastuzumab deruxtecan in two patients with recurrent grade III anaplastic ependymoma.

Journal: Molecular and cellular pediatrics

Published: August 21, 2026

Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer.

Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer.

Journal: Molecular diversity

Published: July 16, 2026

Editor's Note: Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo.

Editor's Note: Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 13, 2026

Effects of ABCG2 knockdown on therapeutic enhancement of 5-aminolevulinic acid with lapatinib.

Effects of ABCG2 knockdown on therapeutic enhancement of 5-aminolevulinic acid with lapatinib.

Journal: Photochemistry and photobiology

Published: July 10, 2026

A CFH- and SPINT2-based prognostic signature for cholangiocarcinoma.

A CFH- and SPINT2-based prognostic signature for cholangiocarcinoma.

Journal: Journal of gastrointestinal oncology

Published: July 09, 2026

Drug-induced paronychia: a disproportionality and time-to-onset pharmacovigilance study using FAERS and JADER.

Drug-induced paronychia: a disproportionality and time-to-onset pharmacovigilance study using FAERS and JADER.

Journal: Cutaneous and ocular toxicology

Published: July 07, 2026

Showing 1-12 of 3,709

Last Updated: 11/08/2026